Search

IDEXX Laboratories Inc

Chiusa

SettoreSettore sanitario

548.88 -3.21

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

548.35

Massimo

566.61

Metriche Chiave

By Trading Economics

Entrata

60M

338M

Vendite

76M

1.2B

P/E

Media del settore

41.144

57.002

EPS

4.27

Margine di Profitto

27.817

Dipendenti

11,000

EBITDA

27M

427M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+23.33% upside

Dividendi

By Acuity

Utili prossimi

2 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

2.1B

47B

Apertura precedente

552.09

Chiusura precedente

548.88

Notizie sul Sentiment di mercato

By Acuity

6%

94%

4 / 340 Classifica in Healthcare

IDEXX Laboratories Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 ago 2026, 23:16 UTC

IDEXX Laboratories Inc shares are trading higher in after-market hours, following a session rebound despite no specific company news identified.

12 ago 2026, 23:01 UTC

IDEXX Laboratories Inc shares are lower in after-market hours, settling down after a brief recovery earlier in the session. No specific news was identified.

11 ago 2026, 23:01 UTC

IDEXX Laboratories Inc is trading higher in after-market hours, maintaining strength above its 20-day moving average and near the upper end of its one-month range.

10 ago 2026, 23:01 UTC

IDEXX Laboratories Inc shares are higher in after-market hours, reaching a recent high. The stock is above its 20-day moving average amid rising Treasury yields.

8 ago 2026, 00:01 UTC

IDEXX Laboratories Inc shares are higher in after-market hours, though no specific news was identified to explain the movement. Volatility has been notable recently.

7 ago 2026, 23:31 UTC

IDEXX Laboratories shares are higher in after-market trading, recovering from earlier losses amid positive market sentiment, particularly from major tech stocks.

6 ago 2026, 21:01 UTC

Correlated Moves

IDEXX Laboratories Inc. gained in after-market trading, supported by broader market movements and resilience in recent jobless claims data.

5 ago 2026, 23:51 UTC

News

IDEXX Laboratories shares rise in after-hours trading as UBS raises price target to $670 while maintaining a Neutral rating.

4 ago 2026, 23:41 UTC

News

IDEXX Laboratories reported second-quarter revenue of $1.22 billion, a 9.7% increase year-over-year. Shares are trading higher in after-market hours following the results.

3 ago 2026, 23:01 UTC

IDEXX Laboratories Inc. shares advanced in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

31 lug 2026, 22:01 UTC

IDEXX Laboratories Inc shares are higher in after-market trading, showing notable volatility since Friday's close with no specific news identified.

30 lug 2026, 22:51 UTC

IDEXX Laboratories Inc is lower in after-market trading, driven by declines in the Health Care Equipment sub-sector. No specific company news was identified.

29 lug 2026, 23:01 UTC

IDEXX Laboratories Inc shares are higher in after-market trading, though no specific news explains the movement amid mixed global market conditions and rising Middle East tensions.

28 lug 2026, 20:06 UTC

Correlated Moves
News

IDEXX Laboratories shares are higher, bolstered by its 2025 Corporate Responsibility Report highlighting innovations and positive trends in the Health Care Equipment sub-sector.

27 lug 2026, 22:22 UTC

Correlated Moves

IDEXX Laboratories shares are lower in after-hours trading, reflecting broader market declines as the S&P 500 Index also dipped slightly.

24 lug 2026, 23:16 UTC

No specific news for IDEXX Laboratories Inc. After-market trading showed little change since Friday's close, remaining within a narrow range.

23 lug 2026, 23:02 UTC

IDEXX Laboratories Inc shares are lower in after-market trading, marking six consecutive sessions of declines. No specific news was identified to explain the movement.

22 lug 2026, 23:11 UTC

IDEXX Laboratories Inc shares are higher in after-market trading, reflecting a notable increase since Wednesday's close amid broader market volatility.

21 lug 2026, 23:06 UTC

IDEXX Laboratories Inc shares are lower in after-market hours, continuing a downward trend from the past four sessions without any specific news identified.

20 lug 2026, 23:01 UTC

IDEXX Laboratories Inc shares advanced in after-market trading, settling at a cumulative return of 0.59%. Broader market dynamics contributed to volatility.

17 lug 2026, 22:16 UTC

IDEXX Laboratories Inc shares are lower in after-market hours. Broader market declines in Asia may be influencing investor sentiment.

16 lug 2026, 23:06 UTC

Correlated Moves

IDEXX Laboratories Inc. shares declined in after-market trading amid broader market trends and geopolitical tensions, despite remaining above the 20-day moving average.

15 lug 2026, 23:01 UTC

IDEXX Laboratories Inc shares are higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.

14 lug 2026, 20:02 UTC

Correlated Moves

IDEXX Laboratories Inc. is declining amid broader weakness in the Health Care Equipment sub-sector, with shares near the lower end of their one-month range.

13 lug 2026, 21:26 UTC

IDEXX Laboratories Inc. is near unchanged in after-market trading, reflecting routine activity as investors await upcoming economic data, including the Consumer Price Index.

10 lug 2026, 21:01 UTC

IDEXX Laboratories Inc shares are higher in after-market hours, continuing a recent upward trend despite a prior dip. No specific news explains the movement.

9 lug 2026, 23:01 UTC

IDEXX Laboratories Inc shares are lower in after-market hours, settling down modestly after a slight decline from a peak shortly after the market closed.

8 lug 2026, 20:51 UTC

Correlated Moves

IDEXX Laboratories Inc. is lower in after-market trading, reflecting broader market weakness and notable losses in European equity markets due to geopolitical uncertainties.

7 lug 2026, 20:02 UTC

Correlated Moves
News

IDEXX Laboratories is rising amid strong gains in the Health Care Equipment sector. Analysts highlight IDEXX's innovations as key to maintaining market share.

6 lug 2026, 23:26 UTC

Correlated Moves

IDEXX Laboratories Inc shares are lower in after-market hours, reflecting broader market declines amid recent data indicating a slowdown in U.S. service sector activity.

Confronto tra pari

Modifica del prezzo

IDEXX Laboratories Inc Previsione

Obiettivo di Prezzo

By TipRanks

23.33% in crescita

Previsioni per 12 mesi

Media 699.17 USD  23.33%

Alto 805 USD

Basso 665 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per IDEXX Laboratories Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

4

Acquista

3

Mantieni

0

Vendi

Sentiment

By Acuity

4 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo IDEXX Laboratories Inc

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
help-icon Live chat